WP
TGTX icon

Woodline Partners’s TG Therapeutics TGTX Stock Holding History

Woodline Partners’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.3M Hold
715,500
– – 0.12% 224
2026
Q1 		$23.8M Buy
+715,500
New +$21.3M 0.09% 297
2025
Q3 		– Sell
-594,620
Closed -$21.4M – 1046
2025
Q2 		$21.4M Buy
594,620
+61,486
+12% +$2.29M 0.11% 272
2025
Q1 		$21M Buy
+533,134
New +$17.9M 0.14% 221
2024
Q4 		– Sell
-2,565,322
Closed -$60M – 997
2024
Q3 		$60M Buy
2,565,322
+1,145,788
+81% +$25M 0.51% 46
2024
Q2 		$25.3M Buy
1,419,534
+14,937
+1% +$238K 0.24% 135
2024
Q1 		$21.4M Sell
1,404,597
-363,837
-21% -$5.8M 0.2% 162
2023
Q4 		$30.2M Buy
1,768,434
+1,616,295
+1,062% +$18.8M 0.33% 91
2023
Q3 		$1.27M Buy
152,139
+10,639
+8% +$148K 0.01% 430
2023
Q2 		$3.51M Buy
+141,500
New +$3.65M 0.04% 346
2023
Q1 		– Sell
-2,562,100
Closed -$30.3M – 773
2022
Q4 		$30.3M Buy
2,562,100
+1,627,664
+174% +$11.8M 0.41% 57
2022
Q3 		$5.53M Buy
+934,436
New +$6.13M 0.08% 274
2021
Q4 		– Sell
-106,932
Closed -$3.56M – 787
2021
Q3 		$3.56M Buy
106,932
+4,952
+5% +$153K 0.06% 307
2021
Q2 		$3.96M Sell
101,980
-824,786
-89% -$32.4M 0.07% 248
2021
Q1 		$44.7M Buy
926,766
+893,514
+2,687% +$42.9M 0.99% 22
2020
Q4 		$1.73M Sell
33,252
-166,623
-83% -$5.63M 0.05% 199
2020
Q3 		$5.35M Sell
199,875
-132,777
-40% -$3.06M 0.18% 125
2020
Q2 		$6.48M Buy
+332,652
New +$5.36M 0.26% 94

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Woodline Partners's TGTX Position: Q2 2026 in Review

Woodline Partners held its TG Therapeutics (TGTX) position steady in Q2 2026 at 715,500 shares worth $39.3M. The position accounts for 0.12% of the portfolio, ranked #224.

Woodline Partners first reported a position in TGTX in Q2 2020 and has held it in 18 quarters since. The position peaked at $60M in Q3 2024. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Woodline Partners held 715,500 shares of TG Therapeutics worth $39.3M as of Q2 2026.
  • Woodline Partners left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up 0.12% of Woodline Partners's portfolio in Q2 2026, its #224 holding.
  • Woodline Partners first reported a position in TG Therapeutics in Q2 2020 and has held it in 18 quarters since.
  • Woodline Partners's TG Therapeutics position peaked at $60M in Q3 2024.
  • 428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.